Predisposing factors of rhino-orbital-cerebral mucormycosis in patients with COVID 19 infection

The predisposing factors of invasive fungal disease in COVID 19 infection are still debatable because of the limited human understanding of the virus with the current literature. In this study, we have tried to correlate the various predisposing factors influencing the clinical profile and treatment...

Full description

Saved in:
Bibliographic Details
Published inIndian journal of otolaryngology, and head, and neck surgery Vol. 74; no. Suppl 2; pp. 3151 - 3157
Main Authors Pradhan, Pradeep, Shaikh, Zaid, Mishra, Abhijeet, Preetam, C., Parida, Pradipta Kumar, Sarkar, Sourav, Samal, Dillip Kumar, Nayak, Anindya, Chadaram, Srinivas, Das, Krishna Kinkar, Chakraborty, Swagata, Sharma, Prity, Aswathi, K. V., Vinusree, K., Mittal, Yash, Sundaram, Kalyana, Swarup, Anurita, Adhikari, Asutosh, Chenniappan, Swathi, Shah, Anwer
Format Journal Article
LanguageEnglish
Published New Delhi Springer India 01.10.2022
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The predisposing factors of invasive fungal disease in COVID 19 infection are still debatable because of the limited human understanding of the virus with the current literature. In this study, we have tried to correlate the various predisposing factors influencing the clinical profile and treatment outcomes in patients with covid associated mucormycosis (CAM). It is a retrospective analysis of cases of CAM during the second wave of COVID 19 infection, which was managed in the department of Otorhinolaryngology from Dec 1, 2020, to June 10, 2021. The detailed clinical, radiological and management of patients with CAM were collected, recorded, evaluated and correlated with the predisposing factors. Of the total, 46 patients, 44(95.65%) were diabetic and 41 patients had a previous history of steroid intake. When clinical parameters were compared between blood sugar < 200 mg/dl and > 200 mg/dl, the old and newly diagnosed diabetes mellitus in patients with CAM, there was no significant differences in any of the above clinical parameters ( p  > 0.05), except the hospital stay ( p  = 0,004). Steroid intake in patients with coexisting DM associated with CAM is considered the most important factor for the development of the CAM. There was are no significant difference in any of the clinical/treatment outcomes in patients with CAM with respect to the initial blood sugar, except for the hospital stay. A large sample size with a long-term follow-up period may be needed for a better understanding of common predisposing factors for the development of CAM.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2231-3796
0973-7707
DOI:10.1007/s12070-021-02875-4